Cancer of the prostate: A nutritional disease?

Urology

Volumn 50, Issue 6, 1997, Pages 840-848

  Fair, William R ^a   Fleshner, Neil E ^a   Heston, Warren ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DAIDZEIN; GENISTEIN; NEUROTENSIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; RETINOL; SELENIUM; TESTOSTERONE; VITAMIN D RECEPTOR;

ANIMAL MODEL; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; FAT INTAKE; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; SOYBEAN; VITAMIN INTAKE;

ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; CARCINOMA; DIET; HUMANS; MALE; NUTRITION DISORDERS; NUTRITION PHYSIOLOGY; PROSTATIC NEOPLASMS;

EID: 0031437794     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00339-7     Document Type: Review

References (61)

1. Miller B, Ries L, Henkey B, and Edwards B (Eds): Cancer Statistics Review 1973-1989, Bethesda, Maryland, National Cancer Institute, 1992, NIH Publication No. 92-2789.
2. Flanders WD: Review: prostate cancer epidemiology. Prostate 5: 621-629, 1984.
3. Dhom G: Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate. J Cancer Res Clin Oncol 106: 210-218, 1983.
4. Sakr WA, Haas GP, Cassin BF, Pontes JE, and Crissman JD: The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 150: 379-385, 1993.
5. Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, and Tulinius H: Latent carcinoma of the prostate at autopsy in seven areas. Int J Cancer 20: 680-688, 1977.
6. Parkin DM, and Muir CS: Cancer incidence in five continents: comparability and quality of data. IARC Sci Publ 120: 45-173, 1992.
7. Cancer occurrence in developing countries. IARC Sci Publ 75: 1-339, 1986.
8. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, and Mack TM: Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63: 963-966, 1991.
9. Muir CS, Nectoux J, and Staszewski J: The epidemiology of prostatic cancer: geographical distribution and time-trends. Acta Oncol 30: 133-140, 1991.
10. Rotkin ID: Studies in the epidemiology of prostatic cancer: expanded sampling. Cancer Treat Rev 61:173-180, 1977.
11. Graham S, Haughey B, Marshall J, Priore R, Byers T, Rzepka T, Mettlin C, and Pontes JE: Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst 70: 687-692, 1983.
12. 61 It is estimated that 30% to 50% of human malignancies may be related to dietary factors, and although the feasibility of trials involving low-fat diets has been proved in ongoing trials for colon and breast cancer, no similar study exists for prostate malignancy. Critics of epidemiologic research argue that data derived from case-control studies are subject to recall bias and are thus artifactual. Indeed, many researchers now believe that the breast cancer-dietary fat hypothesis has been discredited. The major difference between the prostate cancer and breast cancer literature is the remarkable consistency of the cohort studies. In these studies, exposure is determined prospectively and is therefore free from recall bias. In this sense they more closely resemble a clinical trial. The majority of cohort studies involving dietary fat and breast cancer have been negative. We believe that these data justify large-scale trials in the area of prevention of prostate cancer. One such proposed study already submitted for National Institutes of Health funding from a consortium of centers is the Prostate Interventional Nutrition Study (PINS), modeled after the Women's Interventional Nutrition Study, which investigates the effect of low-fat diets in women receiving therapy for node-positive breast cancer. The PINS study will be limited to men who have detectable serum PSA levels but no other clinical evidence of disease after radical prostatectomy. All subjects will receive nutritional guidance, with randomization between a control arm receiving the currently recommended 30% fat diet and an interventional arm in which a 15% fat diet is supplemented with soy protein, vitamin E, and selenium. The end points for evaluation will be compared with progression based on changes in PSA and the time of onset of clinical, as opposed to biochemical, disease. Single-institution trials involving groups thought to be at high risk of developing clinical cancer-including men with persistently elevated PSA levels, two negative prostate biopsies, high-grade prostatic intraepithelial neoplasia on biopsy, and a strong family history of prostate cancer-are being initiated at MSKCC and other institutions.
13. Heshmat MY, Kaul L, Kovi J, Jackson MA, Jackson AG, Jones GW, Edson M, Enterline JP, Worrell RG, and Perry SL: Nutrition and prostate cancer: a case-control study. Prostate 6: 7-17, 1985.
14. Kaul L, Heshmat MY, Kovi J, Jackson MA, Jackson AG, Jones GW, Edson M, Enterline JP, Worrell RG, and Perry SL: The role of diet in prostate cancer. Nutr Cancer 9: 123-128, 1987.
15. Ross RK, Shimizu H, Pagananini-Hill A, Honda G, and Henderson BE: Case control studies of prostate cancer in blacks and whites in Southern California. J Natl Cancer Inst 78: 869-874, 1987.
16. Ohno Y, Yoshida O, Oishi K, Okada K, Yamabe H, and Schroeder FH: Dietary beta-carotene and cancer of the prostate: a case control study in Kyoto, Japan. Cancer Res 48: 1131-1136, 1988.
17. Kolonel LN, Yoshizawa CN, and Hankin JH: Diet and prostate cancer: a case-control study in Hawaii. Am J Epidemiol 127: 999-1012, 1988.
18. Mettlin C, Selenskas S, Natarajan N, and Huben R: Beta-carotene and animal fats and their relationship to prostate cancer risk: a case control study. Cancer 64: 605-612, 1989.
19. West DW, Slattery ML, Robison LM, French TK, and Mahoney AW: Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control 2: 85-94, 1991.
20. Fincham SM, Hill GB, Hanson J, and Wijayasinghe C: Epidemiology of prostatic cancer: a case-control study. Prostate 17: 189-206, 1990.
21. Talamini R, La Vecchia C, Decarli A, Negri E, and Franceschi S: Nutrition, social factors and prostatic cancer in a Northern Italian population. Br J Cancer 53: 817-821, 1986.
22. Walker AR, Walker BF, Tsotetsi NG, Sebitso C, Siwedi D, and Walker AJ: Case-control study of prostate cancer in black patients in Soweto, South Africa. Br J Cancer 65: 438-441, 1992.
23. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, and West DW: Prostate cancer in relation to diet, physical activity, and body size in blacks, whites and Asians in the United States and Canada. J Natl Cancer Inst 87: 652-661, 1995.
24. Snowdon DA, Phillips RL, and Choi W: Diet, obesity and risk of fatal prostate cancer. Am J Epidemiol 120: 244-250, 1984.
25. Severson RK, Nomura AM, Grove JS, and Stemmermann GN: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49: 1857-1860, 1989.
26. Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, Wacholder S, Chien HT, and Blot WJ: Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res 50: 6836-6840, 1990.
27. Mills PK, Beeson WL, Phillips RL, and Fraser GE: Cohort study of diet, lifestyle and prostate cancer in Adventist men. Cancer 64: 598-604, 1989.
28. Giovannucci EM, Rimm EB, Colditz GA, Stamfer MJ, Ascherio A, Chute CC, and Willett WC: A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85: 1571-1579, 1993.
29. Rose DP, Boyer AP, and Wynder EL: International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 58: 2363-2371, 1986.
30. Clinton SK, Palmer SS, Spriggs CE, and Visek WJ: Growth of Dunning transplantable prostate adenocarcinomas in rats fed diets with various fat contents. J Nutr 118: 908-914, 1988.
31. Carroll KK, and Noble RC: Dietary fat in relation to hormonal induction of mammary and prostate carcinoma in Nb rats. Carcinogenesis 81: 851-853, 1987.
32. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, and Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818, 1983.
33. Israeli RS, Powell CT, Corr JG, Fair WR, and Heston WD: Expression of the prostate-specific membrane antigen. Cancer Res 54: 1807-1811, 1994.
34. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, and Heston WD: Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 87: 1456-1462, 1995.
35. Wynder EL, Fujita Y, Harris RE, Hirayama T, and Hiyama T: Comparative epidemiology of cancer between the United States and Japan: a second look. Cancer 67: 746-763, 1991.
36. Aldercreutz H, Markannen H, and Watanabe S: Plasma concentrations of phytoestrogens in Japanese men. Lancet 13: 1209-1210, 1993.
37. Barnes S, Peterson TG, and Coward L. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem Suppl 22: 181-187, 1995.
38. Wang Y, Heston WD, and Fair WR: Soy isoflavones decrease the high-fat promoted growth of human prostate cancer-results of in-vitro and animal studies. J Urol 153: 269A, 1995.
39. Hamalainen E, Aldercreutz H, Puska P, and Pietinen: Diet and serum sex hormones in healthy men. J Steroid Biochem 20: 459-464, 1984.
40. Nomura A, Heilbrun LK, Stemmermann GN, and Judd HL: Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res 48: 3515-3517, 1988.
41. Rose DP, and Cohen LA: Effects of dietary menhaden oil and retinyl acetate on the growth of DU 145 human prostatic adenocarcinoma cells transplanted into athymic nude mice. Carcinogenesis 9: 603-605, 1988.
42. Gann PH, Hennekens CH, Sack FM, Grodstein F, Giovannucci EL, and Stampfer MJ: Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86: 281-286, 1994.
43. Cave WT Jr: Dietary n-3 (omega-3) polyunsaturated fatty acid effects on animal tumorigenesis. FASEB J 5: 2160-2166, 1991.
44. Lands WE: Biochemistry and physiology of n-3 fatty acids. FASEB J 6: 2530-2536, 1992.
45. Rose DP, and Connolly JM: Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 18: 243-254, 1991.
46. Liang T, and Liao S: Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids. Biochem J 285: 557-562, 1992.
47. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stancyk FZ, Pike MS, and Henderson BE: 5 alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339: 887-889, 1992.
48. Miyashita T, Hashimoto T, Gomez G, Townsend CM Jr, Greeley GH, and Thompson JC: Neurotensin secretion in response to intraduodenal and intraileal administration of fat in dogs. Biol Signals 1: 275-281, 1992.
49. Slawin K, Kadmon D, Park SH, Scardino FT, Anzano M, Sporn MB, and Thompson TC: Dietary ferentimide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model. Cancer Res 53: 4461-4465, 1993.
50. Eichholzer M, Stahelin HB, Gey KF, Ludin E, and Bernasconi F: Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 66: 145-150, 1996.
51. Peto R, Doll R, Buckley JD, and Sporn MB: Can dietary beta-carotene materially reduce human cancer rates? Nature 290: 201-208, 1981.
52. During JE, Hebert P, and Hennekins CH: The alpha-tocopherol, beta-carotene lung cancer prevention trial of vitamin E and beta-carotene: the beginning of the answers. Ann Epidemiol 4: 75, 1994.
53. The Alpha-Tocopheral, Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029-1035, 1994.
54. Beyers T, and Perry G: Dietary carotenes, vitamin C and vitamin E as protective antioxidants in human cancers. Ann Rev Nutr 12: 139-159, 1992.
55. McKeown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, and Bruce WR: A randomized trial of vitamins C and E in the prevention of colorectal polyps. Cancer Res 48: 4701-4705, 1988.
56. Hanchette CL, and Schwanz GG: Geographic patterns of prostate cancer mortality: evidence for a protective effect of ultraviolet radiation. Cancer 70: 2861-2869, 1992.
57. Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, and Orentreich N: Vitamin D and prostate caner: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2: 467-472, 1993.
58. Skowronski RJ, Peehl DM, and Feldman D: Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 132: 1952-1960, 1993.
59. Schwartz GG, Hill CC, Oeler TA, Becich MI, and Bahnson RR: 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cell proliferation in vivo. Urology 46: 365-369, 1995.
60. Clark LC, Combs DF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, et al. for the National Prevention of Cancer Study Group: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA 276: 1957-1963, 1996.
61. Wynder EL, and Fair WR: Prostate cancer-nutrition adjunct therapy (editorial). J Urol 156: 1364-1365, 1996.